A critical discovery in cancer investigation is emerging with the use of nanobodies to re-engage mutated p53. This crucial tumor inhibitor protein is frequently inactivated in several kinds of tumors, leading https://guidemysocial.com/story7460048/nanobodies-restore-p53-a-promising-hope-for-malignant-management